Zivo Bioscience, Inc. Common Stock
ZIVO
ZIVO was delisted on the 24th of November, 2023.
12 hedge funds and large institutions have $1.17M invested in Zivo Bioscience, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
9% more funds holding
Funds holding: 11 → 12 (+1)
33% less capital invested
Capital invested by funds: $1.76M → $1.17M (-$585K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.11K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.08K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$309 |
| 4 |
Morgan Stanley
New York
|
+$44 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$105K |
| 2 |
BlackRock
New York
|
-$11.6K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $789K | -$105K | -4,772 | -9% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $276K | +$8.11K | +368 | +2% |
|
|
3
BlackRock
New York
| $39K | -$11.6K | -527 | -19% |
|
4
Wells Fargo
San Francisco,
California
| $33K | – | – | – |
|
|
VCA
5
Verdence Capital Advisors
Hunt Valley,
Maryland
| $28K | – | – | – |
|
|
BC
6
Bartlett & Co
Cincinnati,
Ohio
| $3K | – | – | – |
|
|
BCWM
7
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $2.8K | – | – | – |
|
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | -$2.29K | -104 | -50% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | +$1.08K | +49 | New |
|
|
10
Morgan Stanley
New York
| – | +$44 | +2 | +10% |
|
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$309 | +14 | New |
|
ZIVO Hedge Fund Activity: Q3 2022 in Review
12 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q3 2022, worth a combined $1.17M — down 33% from $1.76M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ZIVO positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $8.11K. The largest seller was Geode Capital Management, cutting an estimated $105K.
- 12 institutional investors held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q3 2022, up from 11 in Q2 2022.
- Funds reported $1.17M of Zivo Bioscience, Inc. Common Stock stock for Q3 2022, down 33% quarter-over-quarter.
- 2 funds opened new Zivo Bioscience, Inc. Common Stock positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest Zivo Bioscience, Inc. Common Stock buyer in Q3 2022 was Vanguard Group, an estimated $8.11K added.
- The largest Zivo Bioscience, Inc. Common Stock seller in Q3 2022 was Geode Capital Management, an estimated $105K sold.
Based on aggregated 13F filings for Q3 2022.